$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

DNA sequences encoding erythropoietin 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12N-005/00
  • C12N-015/00
  • C12N-001/20
  • C12N-001/00
  • C12Q-001/68
  • C07H-015/12
출원번호 US-0675298 (1984-11-30)
발명자 / 주소
  • Lin Fu-Kuen (Thousand Oaks CA)
출원인 / 주소
  • Kiren-Amgen, Inc. (Thousand Oaks CA 02)
인용정보 피인용 횟수 : 281  인용 특허 : 19

초록

Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin (“EPO”) which are characterized in preferred forms by being the product of procaryotic or eucaryotic host expression of an exogenous

대표청구항

A purified and isolated DNA sequence consisting essentially of a DNA sequence encoding a polypeptide having an amino acid sequence sufficiently duplicative of that of erythropoietin to allow possession of the biological property of causing bone marrow cells to increase production of reticulocytes an

이 특허에 인용된 특허 (19)

  1. Egrie, Joan C., A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin.
  2. Cohen Stanley N. (Menlo Park CA) Boyer Herbert W. (Mill Valley CA), Biologically functional molecular chimeras.
  3. Shine John (San Francisco CA), DNA Joining method.
  4. Gilbert Walter (Cambridge MA) Talmadge Karen (Cambridge MA), Mature protein synthesis.
  5. Weissman Sherman M. (New Haven CT) Pereira Dennis (Westerly RI) Sood Ashwani (New Haven CT), Method for cloning genes.
  6. Cohen Stanley N. (Portola Valley CA), Method for synthesizing DNA sequentially.
  7. Goldwasser, Eugene; Kavinsky, Clifford; Weiss, Tania L., Monoclonal anti-erythropoietin.
  8. Takezawa Kenji (Yokohama JPX) Hiratani Hajima (Osaka JPX), Novel erythropoietin product and method for the preparation thereof.
  9. Manis Jack J. (Portage MI), Plasmid and process of isolating same.
  10. Cohen Stanley N. (Portola Valley CA) Boyer Herbert W. (Mill Valley CA), Process for producing biologically functional molecular chimeras.
  11. Chiba Hideo (Uji JPX) Sasaki Ryuzo (Kyoto JPX) Ueda Masatsugu (Kawagoe JPX), Process for producing erythropoietin.
  12. Sugimoto Kaname (Okayama JPX) Hayashibara Yasushi (Okayama JPX), Process for the production of human erythropoietin.
  13. Axel Richard (New York NY) Wigler Michael H. (Cold Spring Harbor NY) Silverstein Saul J. (Irvington NY), Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials.
  14. Gilbert Walter (Cambridge MA) Broome Stephanie A. (Cambridge MA) Villa-Komaroff Lydia J. (Boston MA) Efstratiadis Argiris A. (Cambridge MA), Protein synthesis.
  15. Paddock Gary V. (Mount Pleasant SC), Recombinant cDNA construction method and hybrid nucleotides useful in cloning.
  16. Lee-Huang Sylvia (345 E. 69th St. New York NY 10021), Reverse immunoaffinity chromatography purification method.
  17. Morrissey James H. (Oxford GB2), Silver stains for protein in gels-a modified procedure.
  18. Hamer Dean H. (Washington DC) Gerin John (Bethesda MD), Simian virus recombinant that directs the synthesis of hepatitis B surface antigen.
  19. Falkow Stanley (Seattle WA) Moseley Stephen L. (Kirkland WA), Specific DNA probes in diagnostic microbiology.

이 특허를 인용한 특허 (281)

  1. Southern, Edwin, Analysing polynucleotide sequences.
  2. Southern, Edwin, Analysing polynucleotide sequences.
  3. Mytych, Daniel T.; Chirmule, Narendra; Weeraratne, Dohan K., Anti-erythropoietin antibodies.
  4. Westerman, Mark; Ostland, Vaughn; Han, Huiling; Gutschow, Patrick; Westerman, Keith; Olbina, Gordana, Anti-hepcidin antibodies and uses thereof.
  5. Westerman, Mark; Ostland, Vaughn; Han, Huiling; Gutschow, Patrick; Westerman, Keith; Olbina, Gordana, Anti-hepcidin antibodies and uses thereof.
  6. Westerman, Mark; Ostland, Vaughn; Han, Huiling; Gutschow, Patrick; Westerman, Keith; Olbina, Gordana, Anti-hepcidin antibodies and uses thereof.
  7. Elliott Steven G., Antibodies which activate an erythropoietin receptor.
  8. Elliott,Steven, Antibodies which activate an erythropoietin receptor.
  9. Wang,Elizabeth A.; Wozney,John M.; Rosen,Vicki A., BMP products.
  10. Lam Kit Sang ; Salmon Sydney E., Bio-oligomer libraries and a method of use thereof.
  11. Li,Rebecca H.; Seeherman,Howard, Calcium phosphate delivery vehicles for osteoinductive proteins.
  12. Gillies,Stephen D.; Stein,Pascal A.; Lo,Kin Ming, Cancer treatments including administering IL-2 fusion proteins with modulated selectivity.
  13. MacLeod, James N., Canine erythropoietin gene and recombinant protein.
  14. MacLeod, James N., Canine erythropoietin gene and recombinant protein.
  15. MacLeod,James N., Canine erythropoietin gene and recombinant protein.
  16. Brey, Larry A.; Wood, Thomas E.; Buccellato, Gina M.; Jones, Marvin E.; Chamberlain, Craig S.; Siedle, Allen R., Catalysts, activating agents, support media, and related methodologies useful for making catalyst systems especially when the catalyst is deposited onto the support media using physical vapor deposition.
  17. Brey, Larry A.; Wood, Thomas E.; Buccellato, Gina M.; Jones, Marvin E.; Chamberlain, Craig S.; Siedle, Allen R., Catalysts, activating agents, support media, and related methodologies useful for making catalyst systems especially when the catalyst is deposited onto the support media using physical vapor deposition.
  18. Brey, Larry A.; Wood, Thomas E.; Buccellato, Gina M.; Jones, Marvin E.; Chamberlain, Craig S.; Siedle, Allen R., Catalysts, activating agents, support media, and related methodologies useful for making catalyst systems especially when the catalyst is deposited onto the support media using physical vapor deposition.
  19. Brey, Larry A.; Wood, Thomas E.; Buccellato, Gina M.; Jones, Marvin E.; Chamberlain, Craig S.; Siedle, Allen R., Catalysts, activating agents, support media, and related methodologies useful for making catalyst systems especially when the catalyst is deposited onto the support media using physical vapor deposition.
  20. Brey, Larry A.; Wood, Thomas E.; Buccellato, Gina M.; Jones, Marvin E.; Chamberlain, Craig S.; Siedle, Allen R., Catalysts, activating agents, support media, and related methodologies useful for making catalyst systems especially when the catalyst is deposited onto the support media using physical vapor deposition.
  21. Beck Anton K. (Wellesley MA) Withy Raymond M. (Framingham MA) Zabrecky James R. (Framingham MA) Masiello Nicholas C. (Milford MA), Cell encoding recombinant human erythropoietin.
  22. Colin Gegg ; Olaf Kinstler, Chemical modification of proteins to improve biocompatibility and bioactivity.
  23. Gegg Colin ; Kinstler Olaf, Chemical modification of proteins to improve biocompatibility and bioactivity.
  24. Gregg, Colin; Kinstler, Olaf, Chemical modification of proteins to improve biocompatibility and bioactivity.
  25. DeSauvage, Frederic; Henner, Dennis J., Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same.
  26. Van Heuvel Margaretha,NLX ; Bakhuis Janna Gardina,NLX ; Coutel Yves,FRX ; Harder Abraham,NLX ; De Graaff Leendert Hendrick,NLX ; Flipphi Michel Johannes Anthonie,NLX ; Van Der Veen Peter,NLX ; Visser, Cloning and expression of DNA molecules encoding arabinan-degrading enzymes of fungal origin.
  27. Van Heuvel Margaretha,NLX ; Bakhuis Janna Gardina,NLX ; Coutel Yves,FRX ; Harder Abraham,NLX ; De Graaff Leendert Hendrik,NLX ; Flipphi Michel Johannes Anthonie,NLX ; Van Der Veen Peter,NLX ; Visser , Cloning and expression of DNA molecules incoding arabinan-degrading enzymes of fungal origin.
  28. Thompson, Bradley G.; Weiss, Samuel; Shingo, Tetsuro, Combined regulation of neural cell production.
  29. Cabrera Aquino, Jose Gustavo; Segura Pacheco, Blanca Angelica, Compartmentalized method of nucleic acid delivery and compositions and uses thereof.
  30. Ghosh, Joy; Rutz, Mark Anthony; Tissot-Daguette, Kathrin Ulrike; Splawski, Igor; Roguska, Michael, Compositions and methods for antibodies targeting EPO.
  31. Ghosh, Joy; Rutz, Mark Anthony; Tissot-Daguette, Kathrin Ulrike; Splawski, Igor; Roguska, Michael, Compositions and methods for antibodies targeting Epo.
  32. Clancy,Brian; Pittman,Debra; Seeherman,Howard, Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins.
  33. Cho, Myung-Sam; Chan, Sham-Yuen, Compositions containing factor VIII glycoforms.
  34. Opstelten,Dirk J. E.; UytdeHaag,Alphonsus G. C. M., Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content.
  35. Wrighton Nicholas C. ; Dower William J. ; Chang Ray S. ; Kashyap Arun K. ; Jolliffe Linda K. ; Johnson Dana ; Mulcahy Linda, Compounds and peptides that bind to the erythropoietin receptor.
  36. Eichner, Wolfram; Schimmel, Martin; Hacket, Frank; Kraus, Elmar; Zander, Norbert; Frank, Ronald; Conradt, Harald; Langer, Klaus; Orlando, Michele; Sommermeyer, Klaus, Conjugates of hydroxyalkyl starch and a protein.
  37. Eichner, Wolfram; Schimmel, Martin; Hacket, Frank; Kraus, Elmar; Zander, Norbert; Frank, Ronald; Conradt, Harald; Langer, Klaus; Orlando, Michele; Sommermeyer, Klaus, Conjugates of hydroxyalkyl starch and a protein.
  38. Eichner, Wolfram; Orlando, Michele; Zander, Norbert; Conradt, Harald S.; Hacket, Frank; Langer, Klaus; Frank, Ronald, Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination.
  39. Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Jungheinrich, Cornelius; Scharpf, Roland; Lutterbeck, Katharina; Hemberger, Jurgen; Orlando, Michele, Conjugates of hydroxyalkyl starch and an active agent.
  40. Weiss, Samuel; Gregg, Christopher; Davidoff, Allen; Tucker, Joseph, Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents.
  41. Orlando, Michele; Hemberger, Jurgen; Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Lutterbeck, Katharina; Jungheinrich, Cornelius; Scharpf, Roland, Coupling low-molecular substances to a modified polysaccharide.
  42. Hemberger, Jurgen; Orlando, Michele; Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Lutterbeck, Katharina; Jungheinrich, Cornelius; Scharpf, Roland, Coupling proteins to a modified polysaccharide.
  43. Hemberger, Jurgen; Orlando, Michele; Sommermeyer, Klaus; Eichner, Wolfram; Frie, Sven; Lutterbeck, Katharina; Jungheinrich, Cornelius; Scharpf, Roland, Coupling proteins to a modified polysaccharide.
  44. Yallop, Christopher A., Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom.
  45. Elliott Kathryn J. ; Ellis Steven B. ; Harpold Michael M., DNA and mRNA encoding an .alpha..sub.4 subunit of human neuronal nicotinic acetylcholine receptor and cells transformed with same.
  46. Elliott Kathryn J. ; Ellis Steven B. ; Harpold Michael M., DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor alpha-2 subunit and cells transformed with same.
  47. Gillies, Stephen D.; Stein, Pascal Andre; Lo, Kin-Ming, DNA encoding IL-2 fusion proteins with modulated selectivity.
  48. Wozney,John M.; Celeste,Anthony J.; Thies,R. Scott; Yamaji,Noboru, DNA molecules encoding BMP receptor proteins.
  49. German, Michael S.; Goldfine, Ira D.; Rothman, Stephen S., Delivery of polynucleotides by secretory gland expression.
  50. Murray, Allen K., Determination of recombinant glycosylated proteins and peptides in biological fluids.
  51. Weiss, Samuel; Gregg, Christopher, Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders.
  52. Jones, David H. A.; Bout, Abraham, Efficient production of IgA in recombinant mammalian cells.
  53. Dowd, Jason Everett; Weik, Robert; Hemetsberger, Thomas, Enhanced liquid formulation stability of erythropoietin alpha through purification processing.
  54. Gillies, Stephen D.; Lan, Yan; Holden, Sylvia, Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents.
  55. Gillies, Stephen D.; Burger, Christa; Lo, Kin-Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  56. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  57. Gillies,Stephen D.; Burger,Christa; Lo,Kin Ming, Enhancing the circulating half-life of antibody-based fusion proteins.
  58. Fibi Mathias,DEX ; Stuber Werner,DEX, Erythropoietin (EPO) peptides and antibodies directed against these.
  59. Fibi, Mathias; St?ber, Werner, Erythropoietin (EPO) peptides and antibodies directed against these.
  60. Sytkowski Arthur J. ; Grodberg Jennifer, Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics.
  61. Sortwell,Caryl E.; Collier,Timothy J., Erythropoietin administration to improve graft survival.
  62. Meade,Harry M.; Krane,Ian; Young,Michael, Erythropoietin analog-human serum albumin fusion.
  63. Young, Michael; Meade, Harry; Krane, Ian, Erythropoietin analog-human serum albumin fusion.
  64. Fleer,Reinhard; Fournier,Alain; Guitton,Jean Dominique; Jung,G챕rard; Yeh,Patrice, Erythropoietin and albumin fusion protein, nucleic acids, and methods thereof.
  65. Way,Jeffrey, Erythropoietin forms with improved properties.
  66. Strickland Thomas Wayne, Erythropoietin isoforms.
  67. DeVries,Peter J.; Ostrow,David H.; Reilly,Edward B.; Green,Larry L.; Wieler,James, Erythropoietin receptor binding antibodies.
  68. Duliege, Anne-Marie; Stead, Richard; Leuther, Kerstin; Woodburn, Kathryn Wynne; Naso, Robert Barnett, Erythropoietin receptor peptide formulations and uses.
  69. Lambertus Christiaan Johannes Dorssers NL; Gerard Wagemaker NL; Yvonne Johanna Vos NL; Robert William Van Leen NL; Maria Ludovicus Nicolaas Persoon NL, Expression and purification of human interleukin-3 and muteins thereof.
  70. Barr Philip J. ; Brake Anthony J. ; Kaufman Randal J. ; Tekamp-Olson Patricia ; Wasley Louise ; Wong Polly A., Expression of pace in host cells and methods of use thereof.
  71. Barr Philip J. ; Brake Anthony J. ; Kaufman Randal J. ; Tekamp-Olson Patricia ; Wasley Louise ; Wong Polly A., Expression of pace in host cells and methods of use thereof.
  72. Conneely Orla M. ; Headon Denis R.,IEX ; O'Malley Bert W., Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus.
  73. Li-Wei Hsu TW; Su-Chen Chang TW, Expression system for producing recombinant human erythropoietin, method for purifying secreted human erythropoietin and uses thereof.
  74. Gillies,Stephen D.; Lo,Kin Ming, Expression technology for proteins containing a hybrid isotype antibody moiety.
  75. Cho, Myung-Sam; Chan, Sham-Yuen, Factor VIII glycoforms.
  76. Cho,Myung Sam; Chan,Sham Yuen, Factor VIII glycoforms.
  77. Gillies,Stephen D.; Lo,Kin Ming; Wesolowski, Jr.,John S., Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens.
  78. Gillies,Stephen D.; Lauder,Scott, Fc-erythropoietin fusion protein with improved pharmacokinetics.
  79. Yallop, Christopher A., Fed-batch process for production of erythropoietin in human embryonic retina cells that express adenovirus E1A.
  80. Arvedson, Tara; Dyas, Gregory; Rottman, James B.; Sasu, Barbra; Bi, Xiao-juan; Lee, Grace Ki Jeong; Sheng, Jackie Z., Ferroportin antibodies and methods of use.
  81. Arvedson, Tara; Dyas, Gregory; Rottman, James B.; Sasu, Barbra; Bi, Xiao-juan; Lee, Grace Ki Jeong; Sheng, Jackie Z., Ferroportin antibodies and methods of use.
  82. Fleer, Reinhard; Fournier, Alain; Guitton, Jean-Dominique; Jung, Gerard; Yeh, Patrice, Fusion polypeptides of human serum albumin and a therapeutically active polypeptide.
  83. Fleer,Reinhard; Fournier,Alain; Guitton,Jean Dominique; Jung,G챕rard; Yeh,Patrice, G-CSF and albumin fusion protein.
  84. German Michael ; Goldfine Ira D. ; Rothman Stephen S., Gene delivery by secretory gland expression.
  85. Abruzzese, Ronald V; Mehta, Vidya; Nordstrom, Jeffrey L; Fewell, Jason; O'Malley, Bert; Tsai, Sophia, Gene switch systems employing regulators with decreased dimerization.
  86. German Michael ; Goldfine Ira D. ; Rothman Stephen S., Gene therapy by secretory gland expression.
  87. German, Michael; Goldfine, Ira D.; Rothman, Stephen S., Gene therapy by secretory gland expression.
  88. Elliott,Steven G.; Byrne,Thomas E., Glycosylation analogs of erythropoietin.
  89. Harris, Jr., H. William; Russell, David R.; Nearing, Jacqueline; Betka, Marlies, Growing marine fish in fresh water.
  90. Harris, Jr., H. William; Russell, David R.; Nearing, Jacqueline; Betka, Marlies, Growing marine fish in fresh water.
  91. Harris, Jr.,H. William; Russell,David R.; Nearing,Jacqueline; Betka,Marlies, Growing marine fish in fresh water.
  92. H. William Harris, Jr. ; David R. Russell ; Jacqueline Nearing ; Marlies Betka, Growing marine fish in freshwater.
  93. Conradt, Harald S.; Grabenhorst, Eckart; Nimtz, Manfred; Zander, Norbert; Frank, Ronald; Eichner, Wolfram, Hasylated polypeptides.
  94. Sasu, Barbra; Haniu, Mitsuru; Boone, Thomas Charles; Bi, Xiao-juan; Lee, Grace Ki Jeong; Arvedson, Tara; Winters, Aaron George; Cooke, Keegan; Sheng, Jackie Z., Hepcidin, hepcidin antagonists and methods of use.
  95. Gillies, Stephen D.; Lo, Kin Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  96. Gillies, Stephen D.; Lo, Kin-Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  97. Gillies, Stephen D.; Lo, Kin-Ming; Lan, Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  98. Gillies,Stephen D.; Lo,Kin Ming; Lan,Yan, Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation.
  99. Pecker,Iris, High level expression of recombinant human erythropoietin having a modified 5'-UTR.
  100. Pecker, Iris, High level expression of recombinant human erythropoietin having a modified 5′-UTR.
  101. Stylli, Chari; Beckey, Samuel S.; Shumate, Christopher Bentley; Coassin, Peter J., High throughput chemical handling system.
  102. Crowell, Christopher K., Host cells and culture methods.
  103. Crowell, Christopher K., Host cells comprising alpha 1,2 mannosidase and culture methods thereof.
  104. Crowell, Christopher K., Host cells comprising alpha 1,2 mannosidase and culture methods thereof.
  105. Crowell, Christopher Kenyon, Host cells comprising alpha 1,2 mannosidase and culture methods thereof.
  106. Carcagno, Carlos Miguel; Criscuolo, Marcelo Eduardo; Melo, Carlos Alberto; Vidal, Juan Alejandro, Host cells expressing recombinant human erythropoietin.
  107. Powell, Jerry S., Human erythropoietin gene: high level expression in stably transfected mammalian cells.
  108. Powell Jerry S. (Seattle WA), Human erythropoietin gene; high level expression in stably transfected mammalian cells.
  109. Elliott, Kathryn J.; Ellis, Steven B.; Harpold, Michael M., Human neuronal nicotinic acetylcholine receptor & subunit methods employing same.
  110. Elliott Kathryn J. ; Ellis Steven B. ; Harpold Michael M., Human neuronal nicotinic acetylcholine receptor and cells transformed with same DNA and mRNA encoding an--subunit of.
  111. Elliott Kathryn J. ; Ellis Steven B. ; Harpold Michael M., Human neuronal nicotinic acetylcholine receptor compositions and methods employing same.
  112. Elliott Kathryn J. ; Ellis Steven B. ; Harpold Michael M., Human neuronal nicotinic acetylcholine receptor compositions and methods employing same.
  113. Elliott, Kathryn J.; Harpold, Michael M., Human neuronal nicotinic acetylcholine receptor compositions and methods employing same.
  114. Zander, Norbert; Conradt, Harald S.; Eichner, Wolfram, Hydroxyalkyl starch derivatives.
  115. Zander, Norbert; Conradt, Harald; Eichner, Wolfram, Hydroxyalkyl starch derivatives.
  116. Hacket, Frank; Hey, Thomas; Hauschild, Franziska; Knoller, Helmut; Schimmel, Martin; Sommermeyer, Klaus, Hydroxyalkyl starch derivatives and process for their preparation.
  117. Gillies,Stephen D.; Stein,Pascal A.; Lo,Kin Ming, IL-2 fusion proteins with modulated selectivity.
  118. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Immunocytokine sequences and uses thereof.
  119. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Immunocytokine sequences and uses thereof.
  120. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan X., Immunocytokine sequences and uses thereof.
  121. Li, Rebecca; Seeherman, Howard; Kim, Hyun, Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins.
  122. Li, Rebecca; Seeherman, Howard; Kim, Hyun, Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins.
  123. Kim,Hyun; Li,Rebecca; Pavesio,Alessandra; Callegaro,Lanfranco; Seeherman,Howard; Wozney,John, Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins.
  124. Krapcho Karen J. (Salt Lake City UT) Jackson J. R. Hunter (Salt Lake City UT) VanWagenen Bradford Carr (Salt Lake City UT) Kral ; Jr. Robert Marden (Salt Lake City UT), Insecticidally effective peptides.
  125. Krapcho Karen J. (Salt Lake City UT) Jackson J. R. Hunter (Salt Lake City UT) VanWagenen Bradford Carr (Salt Lake City UT) Kral ; Jr. Robert Marden (Salt Lake City UT), Insecticidally effective peptides.
  126. Conneely Orla M. ; Ward Pauline P., Lactoferrin variants and uses thereof.
  127. Christopher Bentley Shumate ; Peter J. Coassin, Liquid chemical distribution method and apparatus.
  128. Shumate,Christopher Bentley; Coassin,Peter J., Liquid chemical distribution method and apparatus.
  129. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  130. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  131. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  132. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  133. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  134. Pearlman, Andrew; Stern, Baruch S., Long lasting drug formulations.
  135. Patel Avantika C. (Thousand Oaks CA) Ratzkin Barry J. (Thousand Oaks CA), Materials and methods for controlling plasmid copy number and stability.
  136. Calhoun, Darlene V.; Christensen, Robert D., Materials and methods for providing nutrition to neonates.
  137. Fallaux, Frits J.; Hoeben, Robert C.; Bout, Abraham; Valerio, Domenico; van der Eb, Alex J.; Schoutten, Govert, Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer.
  138. Wood William I. (San Mateo CA) Martin Thomas John (Victoria AUX), Method and compositions for making ACSF and ACSF antagonists.
  139. Wood William I. ; Martin Thomas John,AUX ; Suva Larry John,AUX, Method and compositions for making ACSF and ACSF antagonists.
  140. Burke Paul A., Method for fabricating polymer-based controlled-release devices.
  141. Burke Paul A., Method for fabricating polymer-based controlled-release devices.
  142. Zsebo, Krisztina M.; Bosselman, Robert A.; Suggs, Sidney V.; Martin, Francis H., Method for increasing hematopoietic progenitor cells by stem cell factor.
  143. Carcagno, Carlos Miguel; Criscuolo, Marcelo Eduardo; Melo, Carlos Alberto; Vidal, Miguel Alejandro, Method for the massive culture of cells producing recombinant human erythropoietin.
  144. Lehrman Mark A. (Dallas TX) Zeng Yucheng (Kansas City MO), Method for the preparation of cell lines producing Man3GlcNac2 asparagine-linked gylcans and.
  145. Cho, Myung-Sam; Chan, Sham-Yuen, Method for treating bleeding disorders.
  146. Adamson John W. (Bainbridge Island WA) Eschbach Joseph W. (Bellevue WA) Downing Michael R. (Thousand Oaks CA) Egrie Joan C. (Thousand Oaks CA), Method for treating iron overload using EPO.
  147. Ray Bryan L. (Burlington MA) Lin Edmund C. C. (Boston MA) Crea Roberto (San Mateo CA), Method of detecting compounds utilizing genetically modified lambdoid bacteriophage.
  148. Powell, Jerry S., Method of making glycoprotein exhibiting erythropoiesis regulating and glycoprotein produced by this method.
  149. Zsebo, Krisztina M.; Bosselman, Robert A.; Suggs, Sidney V.; Martin, Francis H., Method of stimulating growth of melanocyte cells by administering stem cell factor.
  150. Rosenthal Gary J. (Boulder CO) Gerber Michael J. (Denver CO), Method of stimulating hematopoiesis with hemoglobin.
  151. Zhang,Renwen; Peluso,Diane; Morris,Elisabeth, Methods and compositions for healing and repair of articular cartilage.
  152. Egrie, Joan C.; Elliott, Steven G.; Browne, Jeffrey K.; Sitney, Karen C., Methods and compositions for the prevention and treatment of anemia.
  153. Egrie, Joan C.; Elliott, Steven G.; Browne, Jeffrey K.; Sitney, Karen C., Methods and compositions for the prevention and treatment of anemia.
  154. Egrie, Joan C.; Elliott, Steven G.; Browne, Jeffrey K.; Sitney, Karen C., Methods and compositions for the prevention and treatment of anemia.
  155. Egrie,Joan C.; Elliott,Steven G.; Browne,Jeffrey K.; Sitney,Karen C., Methods and compositions for the prevention and treatment of anemia.
  156. Elliott Steven G., Methods for activating an erythropoietin receptor using antibodies.
  157. H. William Harris, Jr. ; David R. Russell ; Jacqueline Nearing ; Marlies Betka, Methods for raising pre-adult anadromous fish.
  158. H. William Harris, Jr. ; David R. Russell ; Jacqueline Nearing ; Marlies Betka, Methods for raising pre-adult anadromous fish.
  159. H. William Harris, Jr. ; David R. Russell ; Jacqueline Nearing ; Marlies Betka, Methods for raising pre-adult anadromous fish.
  160. Harris, Jr., H. William; Russell, David R.; Nearing, Jacqueline; Betka, Marlies, Methods for raising pre-adult anadromous fish.
  161. Harris, Jr., H. William; Russell, David R.; Nearing, Jacqueline; Betka, Marlies, Methods for raising pre-adult anadromous fish.
  162. Harris, Jr., William; Russell, David R.; Noaring, Jacqueling; Betka, Marlies, Methods for raising pre-adult anadromous fish.
  163. Harris, Jr.,H. William; Russell,David R.; Nearing,Jacqueline; Betka,Marlies, Methods for raising pre-adult anadromous fish.
  164. Harris, Jr.,H. William; Russell,David R.; Nearing,Jacqueline; Betka,Marlies, Methods for raising pre-adult anadromous fish.
  165. Stylli, Chari; Beckey, Samuel S.; Shumate, Christopher Bentley; Coassin, Peter J., Methods for rapidly identifying useful chemicals in liquid sample.
  166. Brines,Michael; Cerami,Anthony; Cerami,Carla, Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin.
  167. Brines,Michael; Cerami,Anthony; Cerami,Carla, Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin.
  168. Wrighton Nicholas C. ; Dower William J. ; Chang Ray S. ; Kashyap Arun K., Methods of administering peptides that bind to the erythropoietin receptor.
  169. Opstelten, Dirk J. E.; UytdeHaag, Alphonsus G. C. M., Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same.
  170. Carcagno,Carlos Miguel; Criscuolo,Marcelo Eduardo; Melo,Carlos Alberto; Vidal,Juan A., Methods of purifying recombinant human erythropoietin from cell culture supernatants.
  171. Cho, Myung-Sam; Chan, Sham-Yuen, Methods of reducing hemorrhage due to surgical procedure.
  172. Gillies, Stephen D.; Lo, Kin Ming, Methods of targeting multiple cytokines.
  173. Wang,Elizabeth; Wozney,John M.; Rosen,Vicki A., Methods of treatment of periodontal disease.
  174. Fleer,Reinhard; Fournier,Alain; Guitton,Jean Dominique; Jung,G챕rard; Yeh,Patrice, Methods of treatment with erythropoietin and albumin fusion protein.
  175. Gillies, Stephen D.; Lo, Kin-Ming; Wesolowski, Jr., John S., Methods of using Fc-cytokine fusion proteins.
  176. Tian, Feng; Hays Putnam, Anna-Maria A.; Song, Frank; Chu, Stephanie; Sheffer, Joseph; Barnett, Richard S.; Siladi, Marc E.; Atkinson, Kyle; Lee, Darin; Canning, Peter C., Modified animal erythropoietin polypeptides and their uses.
  177. Tian, Feng; Hays Putnam, Anna-Maria A.; Song, Frank; Chu, Stephanie; Sheffer, Joseph; Barnett, Richard S.; Siladi, Marc; Atkinson, Kyle; Lee, Darin; Canning, Peter C., Modified animal erythropoietin polypeptides and their uses.
  178. Tian, Feng; Hays Putnam, Anna-Maria A.; Song, Frank; Chu, Stephanie; Sheffer, Joseph; Barnett, Richard S.; Siladi, Marc; Atkinson, Kyle; Lee, Darin; Canning, Peter C., Modified animal erythropoietin polypeptides and their uses.
  179. Tian, Feng; Hays Putnam, Anna-Maria A.; Song, Frank; Chu, Stephanie; Sheffer, Joseph; Barnett, Richard S.; Siladi, Marc; Atkinson, Kyle; Lee, Darin; Canning, Peter C., Modified animal erythropoietin polypeptides and their uses.
  180. Bermudes, David Gordon, Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity.
  181. Guyon, Thierry; Borrelly, Gilles; Gallet, Xavier; Drittanti, Lila; Vega, Manuel, Modified erythropoietin polypeptides and uses thereof for treatment.
  182. Ray Bryan L. (Burlington MA) Lin Edmund C. C. (Boston MA) Crea Roberto (Belmont MA), Modified lambda bacteriophage.
  183. Brines,Michael; Cerami,Anthony; Cerami,Carla, Modulation of excitable tissue function by peripherally administered erythropoietin.
  184. Dorssers Lambertus Christian Johannes,NLX ; Wagemaker Gerard,NLX ; Vos Yvonne Johanna,NLX ; Van Leen Robert Willem,NLX, Molecular cloning and expression of the Pro8 isoform of human IL-3.
  185. Gayed,Atef, Multi-dose erythropoietin formulations.
  186. Mc Kearn, John P.; McWherter, Charles A.; Feng, Yiqing; Summers, Neena L.; Staten, Nicholas R.; Streeter, Philip R.; Woulfe, Susan L.; Minster, Nancy I.; Minnerly, John C., Multi-functional chimeric hematopoietic receptor agonists.
  187. Ralph Peter (Orinda CA) Martin George (Berkeley CA) Piatak Michael (Pleasanton CA) Larrick James W. (Woodside CA), Multifunctional M-CSF proteins and genes encoding therefor.
  188. Ralph Peter ; Martin George ; Piatak Michael ; Larrick James W., Multifunctional M-CSF proteins and genes encoding therefor.
  189. Gillies,Stephen D.; Lo,Kin Ming, Multiple cytokine protein complexes.
  190. Shinnick Thomas (Atlanta GA) Houghten Richard (Solana Beach CA), Mycobacterial recombinants and peptides.
  191. Berezin, Vladimir; Bock, Elisabeth, Neuritogenic peptides.
  192. Berezin, Vladimir; Bock, Elisabeth, Neuritogenic peptides.
  193. Mason Anthony J. ; Seeburg Peter H., Nucleic acid encoding the mature .beta..sub.B chain of inhibin and method for synthesizing polypeptides using such nucl.
  194. Nomura Hideaki (Takasaki JPX) Maruyama Kazutoshi (Maebashi JPX), Oral dosage form of biologically active proteins.
  195. Hu Shaw-Fen Sylvia ; Gudas Jean Marie ; Brankow David William, Overexpressing cyclin D 1 in a eukaryotic cell line.
  196. Balu, Palani, Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use.
  197. Balu,Palani, Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use.
  198. Wrighton Nicholas C. ; Dower William J. ; Chang Ray S. ; Kashyap Arun K., Peptides that bind to the erythropoietin receptor.
  199. Sloey, Christopher J.; Vergara, Camille; Ko, Jason; Li, Tiansheng, Pharmaceutical formulations.
  200. Sloey, Christopher James; Vergara, Camille; Ko, Jason; Li, Tiansheng, Pharmaceutical formulations.
  201. Orlando, Michele; Hemberger, Jurgen; Delbos Krampe, Jeanne, Pharmaceutically active oligosaccharide conjugates.
  202. Weiss, Samuel; Enwere, Emeka; Andersen, Linda; Gregg, Christopher, Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis.
  203. Weiss, Samuel; Enwere, Emeka; Andersen, Linda; Gregg, Christopher, Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis.
  204. Weiss, Samuel; Enwere, Emeka; Andersen, Linda; Gregg, Christopher, Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis.
  205. H. William Harris ; Edward M. Brown ; Steven C. Hebert, Polycation-sensing receptor in aquatic species and methods of use.
  206. Harris,H. William; Brown,Edward M.; Hebert,Steven C., Polycation-sensing receptor in aquatic species and methods of use thereof.
  207. Goldenberg, Merrill; Shan, Daxian; Beekman, Alice; Li, Tiansheng, Polyol/oil suspensions for the sustained release of proteins.
  208. Goldenberg Merrill ; Shan Daxian ; Beekman Alice, Polyol:oil suspensions for the sustained release of proteins.
  209. Gregg, Christopher; Weiss, Samuel, Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin.
  210. Gregg, Christopher; Weiss, Samuel, Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin.
  211. Gayed,Atef, Preserved pharmaceutical formulations.
  212. Yallop,Christopher A., Processes for culturing E1-immortalized cells to increase product yields.
  213. Conneely Orla M. ; Headon Denis R.,IEX ; O'Malley Bert W. ; May Gregory S., Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms.
  214. Apicella, Michael A.; Gibson, Bradford W.; Phillips, Nancy J., Production of complex carbohydrates.
  215. Lin Fu-Kuen, Production of erthropoietin.
  216. Lin Fu-Kuen (Thousand Oaks CA), Production of erythropoietin.
  217. Lin Fu-Kuen (Thousand Oaks CA), Production of erythropoietin.
  218. Crowell, Christopher K.; Grampp, Gustavo E., Production of glycoproteins using manganese.
  219. Crowell, Christopher K.; Grampp, Gustavo E., Production of glycoproteins using manganese.
  220. Crowell, Christopher Kenyon; Grampp, Gustavo Enrique, Production of glycoproteins using manganese.
  221. Conneely Orla M. ; Headon Denis R. ; O'Malley Bert W. ; May Gregory S., Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms.
  222. Conneely Orla M. ; Headon Denis R.,IEX ; O'Malley Bert W. ; May Gregory S., Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms.
  223. Pau, Maria G.; UytdeHaag, Alphonsus G. C. M.; Schouten, Govert J., Production of vaccines.
  224. Pau, Maria Grazia; UytdeHaag, Alphonsus G. C. M., Production of vaccines.
  225. Pau, Maria Grazia; UytdeHaag, Alphonsus G. C. M., Production of vaccines.
  226. Pau, Maria Grazia; UytdeHaag, Alphonsus G. C. M.; Schouten, Govert Johan, Production of vaccines.
  227. Pau,Maria Grazia; UytdeHaag,Alphonsus G. C. M., Production of vaccines.
  228. Marzio,Giuseppe; Pau,Maria Grazia; Opstelten,Dirk Jan Elbertus; Uytdehaag,Alphonsus Gerardus Cornelis Maria, Production of viruses viral isolates and vaccines.
  229. Marzio, Giuseppe; Pau, Maria Grazia; Opstelten, Dirk Jan Elbertus; Uytdehaag, Alphonsus Gerardus Cornelis Maria, Production of viruses, viral isolates and vaccines.
  230. Shingo, Tetsuro; Weiss, Samuel, Prolactin induced increase in neural stem cell numbers.
  231. Shingo, Tetsuro; Weiss, Samuel, Prolactin induced increase in neural stem cell numbers.
  232. Negulescu Paul ; Offermanns Stefan,DEX ; Simon Melvin ; Zuker Charles, Promiscuous G-protein compositions and their use.
  233. Gantier, Rene; Vega, Manuel; Drittanti, Lila; Guyon, Thierry, Protease resistant modified erythropoietin polypeptides.
  234. Brines, Michael; Cerami, Anthony; Cerami, Carla, Protection and enhancement of erythropoietin-responsive cells, tissues and organs.
  235. Brines, Michael; Cerami, Anthony; Cerami, Carla, Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs.
  236. Papisov, Mikhail I., Protein conjugates with a water-soluble biocompatible, biodegradable polymer.
  237. Treco Douglas A. ; Heartlein Michael W. ; Hauge Brian M. ; Selden Richard F, Protein production and delivery.
  238. Treco, Douglas; Heartlein, Michael W.; Selden, Richard F, Protein production and protein delivery.
  239. Gillies, Stephen D.; Way, Jeffrey; Lo, Kin-Ming, Proteins comprising an IgG2 domain.
  240. Stamatoyannopoulos George (Seattle WA), Pulse treatment of hemoglobinopathies with erythropoietin.
  241. Lam Kit Sang (Tucson AZ) Salmon Sydney E. (Tucson AZ), Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof.
  242. Mori Tetsuya,JPX ; Yamamoto Kozo,JPX ; Ohta Tsunetaka,JPX, Recombinant DNA and transformant containing the same.
  243. Delcuve Genevieve,CAX, Recombinant DNA molecules and expression vectors for erythropoietin.
  244. Israel, David; Wolfman, Neil M., Recombinant bone morphogenetic protein heterodimers, compositions and methods of use.
  245. Sytkowski Arthur J. ; Grodberg Jennifer,CAX, Recombinant human erythropoietin mutants.
  246. Arthur J. Sytkowski ; Jennifer Grodberg CA, Recombinant human erythropoietin with altered biological activity.
  247. Aggarwal Bharat B. ; Gray Patrick W. ; Nedwin Glenn E., Recombinant lymphotoxin.
  248. Aggarwal Bharat B. ; Gray Patrick W. ; Nedwin Glenn E., Recombinant lymphotoxin cDNA and variants.
  249. Bout,Abraham; Hateboer,Guus; Verhulst,Karina Cornelia; Uytdehaag,Alphonsus Gerardus; Schouten,Govert Johan, Recombinant protein production in a human cell.
  250. Bout,Abraham; Hateboer,Guus; Verhulst,Karina Cornelia; Uytdehaag,Alphonsus Gerardus; Schouten,Govert Johan, Recombinant protein production in a human cell.
  251. Bout,Abraham; Hateboer,Guus; Verhulst,Karina Cornelia; Uytdehaag,Alphonsus Gerardus; Schouten,Govert John, Recombinant protein production in a human cell.
  252. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan X., Recombinant tumor specific antibody and use thereof.
  253. Gillies, Stephen D.; Lo, Kin-Ming; Qian, Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  254. Gillies,Stephen D.; Lo,Kin Ming; Qian,Susan Xiuqi, Recombinant tumor specific antibody and use thereof.
  255. Looker, Douglas L.; Apostol, Izydor Z.; Brucker, Eric A.; Doyle, Michael P.; Foster, David L.; Glascock, Christopher B.; Hartman, James C.; Lee, Geoffrey F.; Lemon, Douglas D.; Moore, Edwin G.; Richa, Reduced side-effect hemoglobin compositions.
  256. Looker,Douglas L.; Apostol,Izydor Z.; Brucker,Eric A.; Doyle,Michael P.; Foster,David L.; Glascock,Christopher B.; Hartman,James C.; Lee,Geoffrey F.; Lemon,Douglas D.; Moore,Edwin G.; Richards,Jane P, Reduced side-effect hemoglobin compositions.
  257. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  258. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  259. Gillies, Stephen D.; Way, Jeffrey; Hamilton, Anita A., Reducing the immunogenicity of fusion proteins.
  260. Gillies,Stephen D.; Hamilton,Anita A., Reducing the immunogenicity of fusion proteins.
  261. Baker, Tony, Removal of molecular assay interferences.
  262. Zsebo,Krisztina M.; Bosselman,Robert A.; Suggs,Sidney V.; Martin,Francis H., SCF antibody compositions and methods of using the same.
  263. Colin Gegg ; Olaf Kinstler, Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility.
  264. Somers,Fabian; Faict,Dirk, Stabilization of pharmaceutical protein formulations with small peptides.
  265. Gerber Michael J. ; Looker Douglas L. ; Kerwin Bruce A., Stabilized compositions containing hemoglobin.
  266. Chari Stylli ; Samuel S. Beckey ; Christopher Bentley Shumate ; Peter J. Coassin, Systems and methods for rapidly identifying useful chemicals in liquid samples.
  267. Chari Stylli ; Samuel S. Beckey ; Christopher Bentley Shumate ; Peter J. Coassin, Systems and methods for rapidly identifying useful chemicals in liquid samples.
  268. Stylli Chari ; Beckey Samuel S. ; Shumate Christopher Bentley ; Coassin Peter J., Systems and methods for rapidly identifying useful chemicals in liquid samples.
  269. Stylli, Chari; Beckey, Samuel S.; Shumate, Christopher Bentley; Coassin, Peter J., Systems and methods for rapidly identifying useful chemicals in liquid samples.
  270. Treco Douglas ; Heartlein Michael W. ; Selden Richard F, Targeted introduction of DNA into primary or secondary cells and their use for gene therapy.
  271. Celeste,Anthony J.; Wozney,John M.; Rosen,Vicki A.; Wolfman,Neil M.; Thomsen,Gerald H.; Melton,Douglas A., Tendon-inducing compositions.
  272. Celeste,Anthony J.; Wozney,John M.; Rosen,Vicki A.; Wolfman,Neil M.; Thomsen,Gerald H.; Melton,Douglas A., Tendon-inducing methods.
  273. Thompson,Lawrence H., Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects.
  274. Shah, Subodh, Thermosensitive biodegradable hydrogels for sustained delivery of leptin.
  275. Brines, Michael; Cerami, Anthony; Cerami, Carla, Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs.
  276. Brines, Michael; Cerami, Anthony; Coleman, Thomas; Yilmaz, Osman, Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions.
  277. Hateboer, Guus; Havenga, Menzo J. E.; Vogels, Ronald; Holterman, Lennart, Transient protein expression methods.
  278. Plata-Salaman, Carlos; Smith-Swintosky, Virginia, Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin.
  279. Aggarwal Bharat B. (San Mateo CA) Gray Patrick W. (San Francisco CA) Nedwin Glenn E. (Guilford CT), Unglycosylated recombinant human lymphotoxin polypeptides and compositions.
  280. Namen Anthony E. ; Goodwin Raymond G. ; Lupton Stephen D. ; Mochizuki Diane Y., Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors.
  281. Namen Anthony E. ; Goodwin Raymond G. ; Lupton Stephen D. ; Mochizuki Diane Y., Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors.

문의처: helpdesk@kisti.re.kr전화: 080-969-4114

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로